Company: CERO
Filing Date: 2025-08-22
Form Type: 10-Q
Source: 0001213900-25-079898
Chunk: 79

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-08-22
Form: 10-Q
Item: Item 1
Chunk 79
---

General
and administrative expenses consist principally of salaries and related costs for personnel in executive and administrative functions,
including stock-based compensation, travel expenses and recruiting expenses. Other general and administrative expenses include professional
fees for legal, accounting and tax-related services, consulting fees, insurance costs, and investor relations fees.

The
Company anticipates that its general and administrative expenses will increase in the future as the Company increases headcount and contracted
services for operational support for expanded operations and infrastructure. The Company also anticipates that general and administrative
expenses will increase as a result of expenses for accounting, audit, legal and consulting services, as well as costs associated with
maintaining compliance with Nasdaq listing rules and SEC requirements, director and officer liability insurance, investor and public
relations activities and other expenses associated with operating as a public company.

Other
Income (Expense), Net

Other
income (expense), net consists predominantly of interest income from interest bearing bank accounts, interest expense on payables, gains
recorded on settlements reached with vendors on payables, and the gain or loss on the revaluation of earnout and derivative liabilities,
which represents the change in fair value of earnout liabilities or outstanding warrants between periods.

Results
of Operations for the Three Months Ended June 30, 2025 and 2024

    For the Three Months Ended  June 30,  

    2025 (Successor)  
    2024 (Successor)  
    Difference  
    Percentage Change 
  
    Operating expenses: 

    Research and development 
    $2,753,963  
    $2,714,344  
    $39,619  
     1.5%
  
    General and administrative 
     1,969,828  
     2,433,893  
     (464,065) 
     (19.1)%
  
    Total operating expenses 
     4,723,791  
     5,148,237  
     (424,446) 
     8.2%
  
    Loss from operations 
     (4,723,791) 
     (5,148,237) 
     (424,446) 
     8.2%

    Other income (expense): 

    Gain from settlement of liabilities with vendor 
     -  
     447,335  
     (447,335) 
     (100.0)